Tayside professor to fore in long-term health study

Research looks at impact of virus on those who needed hospital care

A Tayside professor is helping research the world’s most comprehensive study into the long-term effects of coronavirus.

Professor James Chalmers of Dundee University has been named as the Scottish lead of the UK-wide programme launched yesterday.

The £8.4 million study will focus on patients who have needed hospital care and will assess the impact of Covid-19 on patient health and their recovery.

Around 10,000 patients are expected to take part, making it the largest comprehensive study in the world to understand and improve the health of Covid 19 survivors.

Prof Chalmers, British Lung Foundation professor of respiratory research at the university, said increasing numbers of patients were reporting long-term consequences of Covid-19 infection.

“Many of my patients feel forgotten because all of the focus has been on treating and preventing the immediate effects of the virus,” he said.

“The message today is that you have not been forgotten and those patients still struggling weeks and months after covid are going to get the support and research they need.”

The study aims to understand why some people recover more quickly than others and why some develop subsequent health problems, as well as identifying the most effective treatments in hospital or afterwards and how to improve patient care after discharge.

Patients will be assessed using advanced imaging, data collection and analysis of blood and lung samples.

The team will then develop trials of new strategies for clinical care, including personalised treatments based on the disease characteristics they show as a result of having Covid-19.

Led by the National Institute for Health Research Leicester Biomedical Research Centre, the study, named PHOSP-COVID, will draw on expertise from 25 organisations across the UK.

It has been given urgent public health research status by the Department of Health and Social Care.

The study will be funded by UK Research and Innovation (UKRI) and the National Institute for Health Research.